Radiation absorbed dose estimates for indium-111-labeled B72.3, an IgG antibody to ovarian and colorectal cancer : MIRD dose estimate report No. 18

Saved in:
Bibliographic Details
Published inThe Journal of nuclear medicine (1978) Vol. 39; no. 4; pp. 671 - 676
Main Authors MARDIROSSIAN, G, BRILL, A. B, HARWOOD, S. J, OLSEN, J, DWYER, K. A, SIEGEL, J. A
Format Journal Article
LanguageEnglish
Published Reston, VA Society of Nuclear Medicine 01.04.1998
Subjects
Antibodies, Monoclonal - pharmacokinetics
Biological and medical sciences
Colorectal Neoplasms - radiotherapy
Contrast media. Radiopharmaceuticals
Diseases of the digestive system
Female
Humans
Indium Radioisotopes - pharmacokinetics
Male
Medical sciences
Oligopeptides - pharmacokinetics
Ovarian Neoplasms - radiotherapy
Pentetic Acid - analogs & derivatives
Pentetic Acid - pharmacokinetics
Pharmacology. Drug treatments
Radioimmunotherapy
Radiotherapy Dosage
Radiotherapy. Instrumental treatment. Physiotherapy. Reeducation. Rehabilitation, orthophony, crenotherapy. Diet therapy and various other treatments (general aspects)
Tissue Distribution
Human
Rectal disease
Estimation
IgG
Monoclonal antibody
Malignant tumor
Indium
Female genital diseases
Colonic disease
Ovarian diseases
Ovary
Radiation dose
Rectum
Immunoradiotherapy
Digestive diseases
Intestinal disease
Colon
Radiopharmaceuticals
Online AccessGet full text

Cover

More Information
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0161-5505
1535-5667